Resultados da pesquisa - Mette Skov Holm

  • A mostrar 1 - 9 resultados de 9
Refinar resultados
  1. 1
    Hypomethylation and up-regulation of<i>PD-1</i>in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation

    Hypomethylation and up-regulation of<i>PD-1</i>in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation Por Andreas Due Ørskov, Marianne Bach Treppendahl, Anni Skovbo, Mette Skov Holm, Lone S. Friis, Marianne Hokland, Kirsten Grønbæk

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial

    Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial Por Magnus Tobiasson, I Dybedahl, Mette Skov Holm, Mohsen Karimi, Lena Brandefors, Hege Garelius, Michael Grövdal, Inge Høgh Dufva, Kirsten Grønbæk, Monika Jansson, Claus Werenberg Marcher, L. Nilsson, Astrid Olsnes Kittang, Anna Porwit, Leonie Saft, Lars Möllgård, Eva Hellström‐Lindberg

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

    Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction ch... Por Michael Grövdal, Mohsen Karimi, Rasheed Khan, Anni Aggerholm, Petar Antunović, Jan Astermark, Per Bernell, Lena-Maria Engström, Lars Kjeldsen, Olle Linder, Lars Nilsson, Anna Olsson, Mette Skov Holm, Jon Magnus Tangen, Jonas Wallvik, G Öberg, Peter Hokland, Sten Eirik W. Jacobsen, Anna Porwit, Eva Hellström‐Lindberg

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet Por Luca Malcovati, Eva Hellström‐Lindberg, David Bowen, Lionel Adès, Jaroslav Čermák, Consuelo del Cañizo, Matteo Giovanni Della Porta, Pierre Fenaux, Norbert Gattermann, Ulrich Germing, Joop H. Jansen, Moshe Mittelman, Ghulam Mufti, Uwe Platzbecker, Guillermo Sanz, Dominik Selleslag, Mette Skov-Holm, Reinhard Stauder, Argiris Symeonidis, Arjan A. van de Loosdrecht, Théo de Witte, Mario Cazzola

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Validation of the revised international prognostic scoring system (<scp>IPSS</scp>‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet <scp>MDS</scp> (<scp>EUMDS</scp>) registry

    Validation of the revised international prognostic scoring system (<scp>IPSS</scp>‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European... Por Louise de Swart, Alex Smith, W. Thomas Johnston, Detlef Haase, Jackie Droste, Pierre Fenaux, Argiris Symeonidis, Guillermo Sanz, Eva Hellström‐Lindberg, Jaroslav Čermák, Ulrich Germing, Reinhard Stauder, Otilia Georgescu, Marius MacKenzie, Luca Malcovati, Mette Skov Holm, António Almeida, Krzysztof Mądry, Borhane Slama, Agnès Guerci‐Bresler, Laurence Sanhès, Odile Beyne‐Rauzy, Elisa Luño, David Bowen, Théo de Witte

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

    Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study Por Reinhard Stauder, Ge Yu, Karin A. Koinig, Timothy Bagguley, Pierre Fenaux, Argiris Symeonidis, Guillermo Sanz, Jaroslav Čermák, Moshe Mittelman, Eva Hellström‐Lindberg, Saskia Langemeijer, Mette Skov Holm, Krzysztof Mądry, Luca Malcovati, Aurelia Tatic, Ulrich Germing, Aleksandar Savić, Corine van Marrewijk, Agnès Guerci‐Bresler, Elisa Luño, Jackie Droste, Fabio Efficace, Alexandra Smith, David Bowen, Théo de Witte

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes

    Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes Por Louise de Swart, Simon Crouch, Marlijn Hoeks, Alex Smith, Saskia Langemeijer, Pierre Fenaux, Argiris Symeonidis, Jaroslav Čermák, Eva Hellström‐Lindberg, Reinhard Stauder, Guillermo Sanz, Moshe Mittelman, Mette Skov Holm, Luca Malcovati, Krzysztof Mądry, Ulrich Germing, Aurelia Tatic, Aleksandar Savić, António Almeida, Njetočka Gredelj-Šimec, Agnès Guerci‐Bresler, Odile Beyne‐Rauzy, Dominic Culligan, Ιoannis Kotsianidis, Raphaël Itzykson, Corine van Marrewijk, Nicole M. A. Blijlevens, David Bowen, Théo de Witte

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

    Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry Por Marlijn Hoeks, Ge Yu, Saskia Langemeijer, Simon Crouch, Louise de Swart, Pierre Fenaux, Argiris Symeonidis, Jaroslav Čermák, Eva Hellström‐Lindberg, Guillermo Sanz, Reinhard Stauder, Mette Skov Holm, Moshe Mittelman, Krzysztof Mądry, Luca Malcovati, Aurelia Tatic, António Almeida, Ulrich Germing, Aleksandar Savić, Njetočka Gredelj Šimec, Dominic Culligan, Raphaël Itzykson, Agnès Guerci‐Bresler, Borhane Slama, Jackie Droste, Corine van Marrewijk, Arjan van de Loosdrecht, Nicole M. A. Blijlevens, Marian van Kraaij, David Bowen, Théo de Witte, Alex Smith

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

    Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo Por Petter Woll, Una Kjällquist, Onima Chowdhury, Helen Doolittle, David C. Wedge, Supat Thongjuea, Rikard Erlandsson, Mtakai Ngara, Kristina Anderson, Qiaolin Deng, Adam J. Mead, Laura Stenson, Alice Giustacchini, Sara Duarte, Eleni Giannoulatou, Stephen Taylor, Mohsen Karimi, Christian Scharenberg, Teresa Mortera‐Blanco, Iain C. Macaulay, Sally-Ann Clark, Ingunn Dybedal, Dag Josefsen, Pierre Fenaux, Peter Hokland, Mette Skov Holm, Mario Cazzola, Luca Malcovati, Sudhir Tauro, David Bowen, Jacqueline Boultwood, Andrea Pellagatti, John E. Pimanda, Ashwin Unnikrishnan, Paresh Vyas, Gudrun Göhring, Brigitte Schlegelberger, Magnus Tobiasson, Gunnar Kvalheim, Stefan N. Constantinescu, Claus Nerlov, Lars Nilsson, Peter J. Campbell, Rickard Sandberg, Elli Papaemmanuil, Eva Hellström‐Lindberg, Sten Linnarsson, Sten Eirik W. Jacobsen

    Publicado em 2014
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: